Evaluating the Efficacy of Artesunate-mefloquine on the Thai-Myanmar Border and the Relative Roles of Resistance Genetic Markers: A Retrospective Cohort Study

Trial Profile

Evaluating the Efficacy of Artesunate-mefloquine on the Thai-Myanmar Border and the Relative Roles of Resistance Genetic Markers: A Retrospective Cohort Study

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Dec 2015

At a glance

  • Drugs Artesunate/mefloquine (Primary)
  • Indications Falciparum malaria; Malaria
  • Focus Therapeutic Use
  • Acronyms MMA
  • Most Recent Events

    • 14 Dec 2015 Status changed from recruiting to completed as per ClinicalTrials.gov record.
    • 08 Dec 2015 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.
    • 30 Apr 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top